Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protective effect of gonadoliberin analogues on ovarian function during antitumour treatment
2007-000230-39Phase 3Completed
- Sponsor
- Endocrine Society of Czech Republic
- Start
- Mar 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of triptorelin in Hodgkin lymphoma (HL), leukemia, primary ovarian insufficiency (POI) and 1 more, sponsored by Endocrine Society of Czech Republic. Primary endpoint: Detection of gonadal damage. Started Mar 2008; status: completed.
02
Drugs
triptorelin
03
Conditions
Hodgkin lymphoma (HL)leukemiaprimary ovarian insufficiency (POI)metrorrhagia
Beyond the preview
Go deeper on 2007-000230-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000230-39.